Annual report pursuant to Section 13 and 15(d)

Condensed Consolidated Statements of Cash Flows

v3.20.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (23,086) $ (22,257)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 223 152
Amortization of debt issuance costs 4
(Gain) loss on change in estimated fair value of contingent royalty obligation (81) 291
Share based compensation 3,205 2,475
Unrealized gain on investments (5)
Inventory write-down 76 364
Fixed asset impairment 35
Non-cash operating lease expense 220
Warrant expense 3,156
Write-down of workstations related to evaluation agreements 332
Amortization of bond premium 33
Changes in operating assets and liabilities:    
Accounts receivable (60) (5)
Inventory (975) (381)
Prepaid expenses and other current assets 155 69
Related party receivable (18)
Accounts payable and accrued expenses 629 744
Operating lease liabilities - current and non-current (216)
Other current and non-current liabilities (21) 94
Net cash used in operating activities (19,915) (14,933)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of fixed assets (468) (547)
Purchase of available-for-sale securities (9,655) (5,043)
Proceeds from sale of available-for-sale securities 4,500 2,000
Purchase of held-to-maturity securities (4,863)
Proceeds from maturity of held-to-maturity securities 4,830
Repayment of shareholder loan receivable 126
Net cash used in investing activities (5,623) (3,497)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Gross proceeds from public offering 20,000 31,000
Proceeds from exercise of over-allotment options 1,945 2,305
Proceeds from issuance of debt 8,000
Proceeds from exercise of options 2 48
Financing fees related to debt and equity financing (1,931) (3,812)
Net cash provided by financing activities 28,016 29,541
NET INCREASE IN CASH AND CASH EQUIVALENTS 2,478 11,111
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 18,050 6,939
CASH AND CASH EQUIVALENTS AT END OF PERIOD 20,528 18,050
CASH PAID FOR:    
Interest
Income taxes
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:    
Reclassification of deferred financing costs from current assets to common stock 602
Cashless exercise of options 2
Financing fees included in accounts payable and accrued expenses $ 234 $ 207